• LAST PRICE
    0.5089
  • TODAY'S CHANGE (%)
    Trending Up0.0273 (5.6686%)
  • Bid / Lots
    0.5150/ 6
  • Ask / Lots
    0.5500/ 20
  • Open / Previous Close
    0.5036 / 0.4816
  • Day Range
    Low 0.4800
    High 0.5100
  • 52 Week Range
    Low 0.3600
    High 5.9700
  • Volume
    210,598
    average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 0.4816
TimeVolumeEFTR
09:32 ET21810.5
09:33 ET9500.5099
09:37 ET5000.51
09:44 ET10000.51
09:50 ET10000.5099
10:06 ET15000.5
10:08 ET29000.5001
10:11 ET2000.5024
10:13 ET31870.504799
10:15 ET9820.5
10:18 ET3000.5
10:24 ET2000.50259
10:26 ET25000.497451
10:38 ET30000.5
10:58 ET3250.484
11:00 ET33890.4839
11:02 ET1000.4838
11:07 ET16500.4838
11:09 ET122440.5
11:12 ET19000.4998
11:14 ET2000.4835
11:18 ET15650.495
11:23 ET52000.487815
11:32 ET15500.5
11:34 ET2000.4901
11:36 ET3000.4901
11:52 ET20000.5022
11:59 ET21000.5001
12:10 ET129010.50005
12:12 ET1000.5
12:17 ET8000.5001
12:32 ET1070.4976
12:33 ET3600.4951
12:39 ET1200.4951
12:46 ET100980.49
12:48 ET325650.48
12:57 ET282700.48
01:00 ET82470.4801
01:15 ET47600.49
01:20 ET1000.49
01:27 ET100000.4999
01:29 ET5710.4975
01:31 ET1010.4975
01:36 ET5000.4999
01:44 ET1000.4975
01:45 ET100000.5019
01:49 ET20000.4988
02:05 ET10000.5048
02:36 ET2800.4991
02:38 ET11000.502
02:48 ET3000.5018
03:10 ET80100.5001
03:21 ET10000.5028
03:32 ET1000.5099
03:33 ET15000.5028
03:35 ET4580.5028
03:51 ET77870.5087
03:53 ET7040.5087
03:55 ET6000.5089
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesEFTR
eFFECTOR Therapeutics Inc
21.3M
3.6x
---
United StatesSNGX
Soligenix Inc
20.8M
-1.4x
---
United StatesENZN
Enzon Pharmaceuticals Inc
20.0M
-7.0x
---
United StatesGOVX
GeoVax Labs Inc
21.9M
-0.3x
---
United StatesCRBP
Corbus Pharmaceuticals Holdings Inc
18.1M
-0.4x
---
United StatesMRKR
Marker Therapeutics Inc
26.1M
-7.2x
---
As of 2023-01-29

Company Information

eFFECTOR Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the development of oncology drugs, such as selective translation regulator inhibitors (STRIs). It uses selective translation regulation technology platform to internally discover a portfolio of small molecule STRI product candidates. Its product candidates target the eIF4F complex and its activating kinase, MNK. The Company's lead product candidate, tomivosertib, is an inhibitor of MNK, and is being evaluated in combination with KEYTRUDA (pembrolizumab), an inhibitor of programed cell death protein 1 (PD-1) in a randomized Phase IIb clinical trial in patients with metastatic non-small cell lung cancer (NSCLC). Its second product candidate, zotatifin, is an inhibitor of eIF4A, a component of the eIF4F complex, and is being evaluated in a Phase I/II clinical trial in patients with certain solid tumors. Its third program is focused on developing inhibitors of eIF4E.

Contact Information

Headquarters
142 North Cedros Avenue Suite B, Suite ASOLANA BEACH, CA, United States 92075
Phone
858-925-8215
Fax
302-655-5049

Executives

Independent Chairman of the Board
Brian Gallagher
President, Chief Executive Officer, Director
Stephen Worland
Chief Financial Officer
Michael Byrnes
Chief Business Officer
Mayank Gandhi
Independent Director
Elizabeth Bhatt

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$21.3M
Revenue (TTM)
$3.2M
Shares Outstanding
41.9M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
---
EPS
$0.14
Book Value
$0.42
P/E Ratio
3.6x
Price/Sales (TTM)
6.7
Price/Cash Flow (TTM)
3.8x
Operating Margin
-1,131.45%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.